Biologics/Immunotherapy News

Mark L. Corbett, MD, FAAAAI, FACAAI, considered medical school early in college before switching to chemical engineering, but that career path did not last.

Benralizumab reduced levels of IgE circulating in the blood among patients with severe eosinophilic asthma but mepolizumab did not, according to a study published in Clinical and Translational Allergy.

Women who received allergen-specific immunotherapy before or during pregnancy experienced no increased risk for adverse pregnancy outcomes, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Patients with chronic spontaneous urticaria demonstrated improved outcomes related to idiopathic angioedema after taking omalizumab, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Clinicians should evaluate the psychological needs of patients undergoing OIT for food allergy and recommend support when it is warranted, according to a study published in Clinical and Translational Allergy.

Patients taking dupilumab for atopic dermatitis who developed COVID-19 had lower levels of antibodies and milder symptoms than patients on other treatments, according to a study published in Annals of Allergy, Asthma & Immunology.

Cashew oral immunotherapy desensitized most children with cashew allergy as well as those with a co-allergy to pistachio and had a similar safety profile to other food-related oral immunotherapies, according to a study published in Allergy.

As Healio celebrates National Doctors' Day today, we recognize dedicated physicians we spoke with over the past year about how they are working both in the clinic and beyond to improve allergy, asthma and immunology care.

Patients with severe asthma saw significant reductions in exacerbations, oral corticosteroid use, exacerbation-related health care resource utilization and medical costs with benralizumab, according to recent research.

Itaconate and its derivative 4-octyl itaconate inhibit the Januse kinase 1 immune protein, which has implications for potential severe asthma treatment, according to a study published in Cell Metabolism.